Baird Financial Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
Baird Financial Group's NEO Position: Q4 2022 in Review
Baird Financial Group sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 16,270 shares — an estimated $140K sold.
Baird Financial Group first reported a position in NEO in Q2 2019 and held it in 14 quarters. The position peaked at $743K in Q4 2020. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.
- Baird Financial Group reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
- Baird Financial Group sold 16,270 NeoGenomics shares in Q4 2022, an estimated $140K.
- Baird Financial Group first reported a position in NeoGenomics in Q2 2019 and held it in 14 quarters.
- Baird Financial Group's NeoGenomics position peaked at $743K in Q4 2020.
- 242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.
Based on Baird Financial Group's 13F filing for Q4 2022, filed 13 Feb 2023.